Cavernous hemangioma of the liver: role of percutaneous biopsy.
- 1 January 1988
- journal article
- research article
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 166 (1) , 135-138
- https://doi.org/10.1148/radiology.166.1.3275965
Abstract
Fifteen patients with liver masses detected with imaging were strongly considered clinically to have malignant disease. In each case, the possibility of a heptatic cavernous hemangioma was raised upon review of the images. With use of a 20-gauge Franseen needle, a percutaneous hepatic biopsy was performed in all 15 cases, and the diagnosis of cavernous hemangioma was confirmed. There were no complications from the biopsy. Twelve biopsies were performed on a outpatient basis. On the basis of the biopsy results, the care and treatment of each patient were significantly altered. When imaging data are not sufficient to determine that a liver mass is benign, even if the possibility of cavernous hemangioma is entertained, a percutaneous biopsy can be safely performed and can yield a specific histologic diagnosis.This publication has 2 references indexed in Scilit:
- Hepatic cavernous hemangioma: diagnosis with 99mTc-labeled red cells and single-photon emission CTAmerican Journal of Roentgenology, 1987
- Computed tomography in the diagnosis of cavernous hemangioma of the liverAmerican Journal of Roentgenology, 1980